About PetaGene
PetaGene is a Healthcare company based in Cambridge (United Kingdom) founded in 2015 by Alban Rrustemi, and was acquired by Storj in October 2024. Provider of cloud-based software for genetic data storage, transfer and remote access. It operates in the Healthcare and Technology sectors. PetaGene has raised $2.52 million across 3 funding rounds from investors including Storj, Entrepreneur First and Romulus Capital. The company has 11 employees. PetaGene was last valued at $4.3 million in April 2017. PetaGene offers products and services including PetaSuite, PetaSuite Cloud Edition, and PetaSuite Protect. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions. Its legal entity is PETAGENE LTD.
Company details
Founded in 2015 and based in Cambridge, United Kingdom, PetaGene operates in the biotechnology sector by delivering cloud-based solutions for genetic data management. Services such as PetaSuite, PetaLink Cloud Edition, and PetaSuite Protect are provided, enabling data compression, encryption, analysis, and auditing. Integration with existing storage and bioinformatics systems is supported, facilitating efficient storage and transfer while maintaining genotyping accuracy.
- Headquarters Cambridge, United Kingdom
- Employees 11
- Founders Alban Rrustemi
- Stage Acquired
- SectorsHealthcareTechnology
- Email••••••••
- Website petagene.com
- Social LinkedIn X
- Acquired by Storj (Oct 2024)
- Legal Name Petagene Ltd
- Date of Incorporation 04 Apr, 2016
- Jurisdiction HAVERHILL, SUFFOLK, UNITED KINGDOM
Products & Services of PetaGene
PetaGene offers a comprehensive portfolio of products and services, including PetaSuite, PetaSuite Cloud Edition, and PetaSuite Protect.
Lossless compression for genomic data files
Cloud-based compression and remote data access
Encrypted compression for secure genomic data handling
Funding Insights of PetaGene
PetaGene has successfully raised a total of $2.52M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $2.1 million completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.52M
- Total Rounds 3
- Last Round Seed — $2.1M
- Investors Count 2
All 3 funding rounds of PetaGene with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2018 | $2.1M | Seed | – | Romulus Capital | |
| Apr 2017 | $415,000 | Seed | $4.3M | Romulus Capital | – |
| Jun 2016 | Seed | $11,658 | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Apr 2017 | $4.3M | •••••••• |
Last known valuation $4.3M (Apr 2017). 3 investors in total: 3 institutional.
Investors in PetaGene
PetaGene has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Storj, Entrepreneur First and Romulus Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of a program turning individuals into funded technology company founders | joinef.com | London, United Kingdom | ||
Early-stage VC firm investing in the US | romuluscap.com | Boston, United States | ||
Decentralized cloud storage is provided via blockchain and peer-to-peer networks. | 2014 | storj.io | Atlanta, United States |
Investor details for PetaGene
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PetaGene
3 people are tracked at PetaGene (2 in leadership, 1 in team); the tracked headcount is 11.
| Name | Role | Group |
|---|---|---|
Alban Rrustemi | Co-Founder | Leadership |
Vaughan Wittorff | Co-Founder and Chief Commercial Officer | Leadership |
Mar Sánchez Gadea | Product Marketing Manager | Team |
Complete people profiles for PetaGene
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PetaGene
5 dated milestones of PetaGene across 9 years, from founding to its latest funding, stage changes and deals.
- Founded PetaGene is founded.
- Funding First funding round.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $2.1M.
- Exit Acquired by Storj.
Web traffic of PetaGene
The website of PetaGene (petagene.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▼ 9.5% vs previous month
Top companies in Genomics & Gene Therapy Platforms
2 companies that operate in the same segment as PetaGene (Genomics & Gene Therapy Platforms) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Petagene
Complete news archive for PetaGene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PetaGene
PetaGene was founded in 2015 and raised its 1st funding round 1 year after it was founded.
PetaGene is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
PetaGene is a funded company, having raised a total of $2.52M across 3 funding rounds to date.
PetaGene has 11 employees.
Founded in 2015 and based in Cambridge, United Kingdom, PetaGene operates in the biotechnology sector by delivering cloud-based solutions for genetic data management. Services such as PetaSuite, PetaLink Cloud Edition, and PetaSuite Protect are provided, enabling data compression, encryption, analysis, and auditing. Integration with existing storage and bioinformatics systems is supported, facilitating efficient storage and transfer while maintaining genotyping accuracy.
PetaGene offers PetaSuite, PetaSuite Cloud Edition, and PetaSuite Protect.
PetaGene has 3 investors. Key investors include Storj, Entrepreneur First, and Romulus Capital.
The valuation of PetaGene is $4.3M as of Apr 2017.
PetaGene operates through Petagene Ltd.
Yes. PetaGene was acquired by Storj in October 2024.